Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William J Gradishar

Showing results (31-40 of 195) with videos related to

Pageof 20
Sort By:
Cancer Treatment and Research|January 20, 2018
Advances in Endocrine Therapy for Postmenopausal Metastatic Breast CancerLisa E Flaum, William J Gradishar
The Oncologist|August 19, 2018
Adjuvant Anthracyclines in Breast Cancer: What Is Their Role?Ami N Shah, William J Gradishar
Current Treatment Options in Oncology|February 4, 2006
Gene expression in breast cancerVirginia G Kaklamani, William J Gradishar
The Oncologist|March 19, 2017
Endocrine Therapy in the Current Management of Postmenopausal Estrogen Receptor-Positive Metastatic Breast CancerVirginia G Kaklamani, William J Gradishar
International Journal of Clinical Oncology|September 5, 2003
Progress in systemic adjuvant therapy of early-stage breast cancerWilliam J Gradishar, Ruth M O'Regan
Cancer Chemotherapy and Biological Response Modifiers|September 2, 2004
Advances in endocrine therapy for the treatment and prevention of breast cancerWilliam J Gradishar, V Craig Jordan
Cancer Chemotherapy and Biological Response Modifiers|April 22, 2003
The evolving role of endocrine therapy for the treatment and prevention of breast cancerWilliam J Gradishar, V Craig Jordan
Clinical Breast Cancer|May 21, 2003
Epirubicin versus doxorubicin: which is the anthracycline of choice for the treatment of breast cancer?Virginia G Kaklamani, William J Gradishar
Breast Cancer (Tokyo, Japan)|April 29, 2005
The evolving role of endocrine therapy for early stage breast cancerJennifer B Manders, William J Gradishar
JAMA|March 3, 2005
Adjuvant therapy of breast cancer in the elderly: does one size fit all?William J Gradishar, Virginia G Kaklamani
Pageof 20

Showing results (31-40 of 195) with videos related to

Sort By:
Pageof 20
Cancer Treatment and Research|January 20, 2018
Advances in Endocrine Therapy for Postmenopausal Metastatic Breast CancerLisa E Flaum, William J Gradishar
The Oncologist|August 19, 2018
Adjuvant Anthracyclines in Breast Cancer: What Is Their Role?Ami N Shah, William J Gradishar
Current Treatment Options in Oncology|February 4, 2006
Gene expression in breast cancerVirginia G Kaklamani, William J Gradishar
The Oncologist|March 19, 2017
Endocrine Therapy in the Current Management of Postmenopausal Estrogen Receptor-Positive Metastatic Breast CancerVirginia G Kaklamani, William J Gradishar
International Journal of Clinical Oncology|September 5, 2003
Progress in systemic adjuvant therapy of early-stage breast cancerWilliam J Gradishar, Ruth M O'Regan
Cancer Chemotherapy and Biological Response Modifiers|September 2, 2004
Advances in endocrine therapy for the treatment and prevention of breast cancerWilliam J Gradishar, V Craig Jordan
Cancer Chemotherapy and Biological Response Modifiers|April 22, 2003
The evolving role of endocrine therapy for the treatment and prevention of breast cancerWilliam J Gradishar, V Craig Jordan
Clinical Breast Cancer|May 21, 2003
Epirubicin versus doxorubicin: which is the anthracycline of choice for the treatment of breast cancer?Virginia G Kaklamani, William J Gradishar
Breast Cancer (Tokyo, Japan)|April 29, 2005
The evolving role of endocrine therapy for early stage breast cancerJennifer B Manders, William J Gradishar
JAMA|March 3, 2005
Adjuvant therapy of breast cancer in the elderly: does one size fit all?William J Gradishar, Virginia G Kaklamani
Pageof 20